Market Estimates
Valuation Metrics
Financials
Trading Trends
TPST News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Tempest Therapeutics Inc (TPST) stock price today?
The current price of TPST is 2.88 USD — it has increased 2.49 % in the last trading day.
What is Tempest Therapeutics Inc (TPST)'s business?
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a range of tumors. Its two clinical-stage therapeutic product candidates are Amezalpat and TPST-1495. Amezalpat is an oral, small molecule, selective antagonist of peroxisome proliferator-activated receptor alpha. The ongoing global randomized Phase Ib/II trial of Amezalpat combined with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma. The Company’s second clinical program, TPST-1495, a dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, a pathway implicated in multiple cancers.
What is the price predicton of TPST Stock?
Wall Street analysts forecast TPST stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for TPST is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Tempest Therapeutics Inc (TPST)'s revenue for the last quarter?
Tempest Therapeutics Inc revenue for the last quarter amounts to -3.60M USD, decreased -65.91 % YoY.
What is Tempest Therapeutics Inc (TPST)'s earnings per share (EPS) for the last quarter?
Tempest Therapeutics Inc. EPS for the last quarter amounts to -6779000.00 USD, decreased -33.52 % YoY.
What changes have occurred in the market's expectations for Tempest Therapeutics Inc (TPST)'s fundamentals?
How many employees does Tempest Therapeutics Inc (TPST). have?
Tempest Therapeutics Inc (TPST) has 24 emplpoyees as of January 09 2026.
What is Tempest Therapeutics Inc (TPST) market cap?
Today TPST has the market capitalization of 14.39M USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fdefault_image%2Fnewsfilter.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F11b3063d1661079ee4af345b835c2a4fc20bd2d988e3925919c16f61c892c939.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F9348a128931466e1d11e72df6b1c980b2929d209ec47822420c280d15b05f321.png&w=384&q=75)